Artificial intelligence, or AI, is rapidly transforming the world of medicine. AI computers are diagnosing medical conditions at a rate equal to or better than humans, all while developing their own code and algorithms to do so. With the rise of AI, there are new issues of patentability, inventorship, and ownership that must be addressed. In this podcast, Finnegan partner Susan Tull discusses current issues surrounding intellectual property and AI in medicine.
Conference
Licensing Executives Society Chinese Taipei – Annual Conference 2026
December 4, 2026
Taipei
Webinar
Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe
November 19, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.